Drug Topics
APRIL 15, 2025
On behalf of 39 state and territory attorneys general, the National Association of Attorneys General issued a letter to Congress regarding major PBMs conflicts of interest.
STAT
APRIL 15, 2025
A new federal report suggests that U.S. autism rates are rising modestly, an increase that health researchers said reflected expanded diagnostic tools and access to care, among other factors. But health secretary Robert F. Kennedy Jr. instead has pointed to the data as evidence of a growing crisis. The Centers for Disease Control and Prevention report says that 3.2% of kids surveyed in 2022 have autism spectrum disorder, a slight uptick from the 2.8% of kids surveyed in 2020 for the previous rep
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Drug Topics
APRIL 15, 2025
The FDA approved adalimumab-aaty in May 2023 for 8 indications, including rheumatoid arthritis, psoriatic arthritis, Crohn disease, ulcerative colitis, and plaque psoriasis.
The Checkup by Singlecare
APRIL 15, 2025
Many people are interested in generic drug availability since brand-name drugs are often costly. Mounjaro (tirzepatide) is a brand-name prescription medication that is approved by the Food and Drug Administration (FDA) to improve blood sugar levels in people with Type 2 diabetes. It is also commonly used off-label for weight loss because, as a dual glucose-dependent insulinotropic polypeptide (GIP) receptor and glucagon-like peptide-1 (GLP-1) receptor agonist, tirzepatide helps control appetite
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Drug Topics
APRIL 15, 2025
One asymptomatic patient did experience drug-induced liver injury that was resolved after discontinuation of danuglipron.
STAT
APRIL 15, 2025
A meeting of vaccine advisers long targeted by Health Secretary Robert F. Kennedy Jr. unfolded Tuesday seemingly without fireworks or interference, although the new administration’s imprint could be seen from the start, when staff for the Centers for Disease Control and Prevention, gutted by layoffs, struggled to get a livestream running.
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
PharmaVoice
APRIL 15, 2025
Brian Thompson’s murder has raised questions about the cost of U.S. healthcare, embroiling insurers, drugmakers and PBMs in a battle for the future of the industry.
Drug Topics
APRIL 15, 2025
Mark Garofoli, PharmD, MBA, BCGP, CPE, CTTS, discusses effective strategies for balancing excellent patient care with strict regulations surrounding controlled substances.
The Checkup by Singlecare
APRIL 15, 2025
GIP/GLP-1 agonists, like Zepbound ( tirzepatide ), are prescription medications that have had a massive surge in popularity over the past years. In fact, one in eight adults has taken a GLP-1 agonist medication at some point, according to the latest data from KFF. Semaglutide medications , like Ozempic and Wegovy , are probably the best-known GLP-1 drugs on the market.
Pharmacy Times
APRIL 15, 2025
SOC emphasizes adaptability and individual professional judgment without compromising quality as individuals are held to the standard and expertise of their practice area
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Pharmaceutical Technology
APRIL 15, 2025
At the ESCMID Global conference in Austria, the development of climate-informed infectious disease risk management systems was discussed.
pharmaphorum
APRIL 15, 2025
The US has launched a national security probe into the national security implications of importing pharmaceuticals, seen as a precursor to tariffs.
Fierce Healthcare
APRIL 15, 2025
A three-day conference earlier this month gave a glimpse into stakeholders' view on the future of Medicare Advantage, C-SNP plans and the remaking of the federal health offices
Pharmacy Times
APRIL 15, 2025
Monica Sawiris, PharmD, said there were noticeable differences in toxicities between each regimen.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
Fierce Healthcare
APRIL 15, 2025
A cancer diagnosis can introduce a swarm of confusion and new protocols for patients. Reimagine Care provides patients with on-demand oncology expertise at all times of the day and night.
Pharmacy Times
APRIL 15, 2025
The designation was supported based on data from the randomized, double-blind, active-controlled phase 3 interchangeability study.
Fierce Healthcare
APRIL 15, 2025
A benchmarking analysis conducted among dozens of organizations again found healthcare to be "more reactive than proactive" when it comes to cybersecurity.
Pharmacy Times
APRIL 15, 2025
Patients who received a pneumococcal conjugate vaccine 13 vaccination had slightly lower incidence of severe COVID-19 outcomes, but the directions of these associations were mixed.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
pharmaphorum
APRIL 15, 2025
Sanofi is preparing a phase 3 programme for asthma candidate amlitelimab, despite mixed data in a phase 2 trial.
Pharmacy Times
APRIL 15, 2025
UPMC enhances heart failure patient care through integrated pharmacy and cardiology team collaboration.
pharmaphorum
APRIL 15, 2025
Explore how the EU healthcare industry is leveraging data, digitalisation, and artificial intelligence to revolutionise medicines regulation. Learn about the advancements and benefits of this new era.
Pharmacy Times
APRIL 15, 2025
Data indicate potential benefits and risks with nutritional supplement use, highlighting the need for pharmacist counseling.
pharmaphorum
APRIL 15, 2025
Netherlands-based pharma group Norgine has expanded its rare disease portfolio with the acquisition of France's Theravia for an undisclosed sum
Pharmacy Times
APRIL 15, 2025
Panelists discuss how evolving clinical guidelines for intensive low-density lipoprotein cholesterol (LDL-C)lowering therapies have shaped personalized treatment approaches through risk stratification, with different targets for primary vs secondary prevention and consideration of genetic factors when determining appropriate statin intensity.
pharmaphorum
APRIL 15, 2025
Shares in Ironwood fell by a third after it revealed the FDA is insisting on a new phase 3 trial of its short bowel syndrome therapy apraglutide
Pharmacy Times
APRIL 15, 2025
Strategies for rescuing PTPRD function in diseased livers could provide potential therapeutic options, wrote the study authors.
Pharmaceutical Technology
APRIL 15, 2025
The FDA will require an additional Phase III trial for apraglutide, the company's candidate for short bowel syndrome.
Fierce Healthcare
APRIL 15, 2025
More specialties reported cuts to their average total compensation than increases in a new annual survey, and four specialties are now bringing home over half a million. Here's the breakdown.
Pharmaceutical Commerce
APRIL 15, 2025
Will Robinson, program director, LogiPharma, reveals why the conference will be moved to Vienna moving forward.
PharmExec
APRIL 15, 2025
OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.
Pharmaceutical Commerce
APRIL 15, 2025
Access USA converges in Philadelphia to explore newand neededsolutions to boost patient outcomes.
PharmExec
APRIL 15, 2025
In the Phase III ODYSSEY-HCM trial, patients treated with Camzyos for symptomatic non-obstructive hypertrophic cardiomyopathy did not show significant improvements based on Kansas City Cardiomyopathy Questionnaire Clinical Summary Scores and peak oxygen consumption.
Pharmaceutical Commerce
APRIL 15, 2025
One expert's take on reshoring pharma manufacturing services in the US amid likely tariffs to drugs looming.
Expert insights. Personalized for you.
560 
Let's personalize your content